ProRx Pharma Introduces New Liquid Nanoemulsion Delivery System to Support Enhanced Absorption, Bioavailability, and Patient Convenience
CLICK HERE TO READ THE ORIGINAL ARTICLE Compounder Is the Only 503B Outsourcing Facility in the United States to Have Rights to Patented Technology PRESS RELEASE FROM PRORX PHARMA Nov. 6, 2025 EXTON, Pa. — ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the launch of its new Liquid Nanoemulsion Delivery System, which […]
ProRx Pharma Achieves DEA Registration for Controlled Substances
FULL ARTICLE HERE By Caleb Price | September 24, 2025 Certification Expands Capabilities, Strengthens Compliance, and Supports Provider Partnerships ProRx Pharma, a notable player in the health and wellness outsourcing sector, has received a DEA Controlled Substances Registration Certificate. This important achievement allows the company to manage and distribute specific controlled substances, broadening the scope […]
What You’re Getting Wrong About 503B Outsourcing Facilities – And Why It Matters for Patient Care
FULL ARTICLE HERE By Daniel Casciato | August 15, 2025 In today’s healthcare environment, patient-centered care is no longer just a buzzword; it’s a necessity. As personalized medicine and preventative health take center stage, the demand for customized compounded sterile preparations is surging. But while the need is growing, so is the confusion, especially when it comes […]
ProRx Highlights Role of 503B Outsourcing in Patient-Centered Wellness Care
08/08/2025 – SEE ARTICLE HERE In recognition of National Wellness Month, ProRx, an FDA-registered 503B outsourcing facility, is emphasizing the clinical value of personalized, high-quality compounded therapies in wellness-focused care models. ProRx provides sterile and non-sterile compounded medications for office use to a range of healthcare providers, including wellness clinics, hormone therapy centers, and aesthetic […]
Growing Role of Compound Pharmacies in Precision Medicine with Kurt Lunkwitz
Kurt Lunkwitz, Chief Operating Officer at ProRx Pharma, describes the role compound pharmacies play in filling gaps when certain drugs are in short supply and providing personalized medications for patients.
How men can utilize benefits to support their health
By Lee Hafner – ARTICLE HERE Men are taking a more proactive approach to their health. Benefit managers can showcase company support with targeted offerings and communication. Helping men focus on preventative healthcare can’t come soon enough: Men currently have an increased risk for heart attack, stroke and cancer, and die by suicide four times as often […]
ProRx Pharma Launches Preventative Health Line with Four New Products
ARTICLE HERE The new product line includes Sermorelin, NAD+, Glutathione and MIC/B6/B12 to help meet demand as physicians and patients focus more on preventative health measures EXTON, Pa., April 7, 2025 /PRNewswire/ — ProRx Pharma, the health and wellness 503B outsourcing facility, today announced the launch of four new injectables in its health and wellness […]
ProRx Pharma Expands Health Line with Innovative New Products
By Olivia Taylor – ARTICLE HERE ProRx Pharma Expands Health Line with Innovative New Products The new product line includes Sermorelin, NAD+, Glutathione, and MIC/B6/B12, designed to cater to the rising demand as healthcare providers and patients shift their focus towards preventative health measures. Launch of New Injectable Products ProRx Pharma, a leading health and […]
ProRx Pharma, Gatlan partner on men’s health, wellness products
By Sandra Levy – ARTICLE HERE Gatlan offers testosterone replacement therapy, weight loss, hair regrowth treatments and other products for men. ProRx Pharma, a health and wellness 503B outsourcing facility, is partnering with Gatlan, a men’s health brand launched by actor and director Josh Duhamel. Gatlan offers testosterone replacement therapy, weight loss, hair regrowth treatments […]
FDA Oversight and DQSA Guidelines Ensure Compliance for 503B Outsourcing Facilities
by Mark Chiang – ARTICLE HERE Kurt Lunkwitz, Chief Operating Officer of ProRx Pharma, outlined the regulatory framework governing 503B outsourcing facilities during a recent discussion. He detailed the strict requirements these facilities must meet under the Drug Quality and Security Act (DQSA). Lunkwitz also addressed the role of the U.S. Food and Drug Administration […]